Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma

Intermediate-stage hepatocellular carcinoma (HCC) consists of heterogeneous groups of patients in terms of tumor burden and organ function reserves. Although liver-directed therapy (LDT), including trans-catheter arterial chemoembolization, radiofrequency ablation or even surgical resection, is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yung-Yeh, Liu, Yi-Sheng, Hsiao, Chin-Fu, Hsu, Chiun, Chen, Li-Tzong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170176/
https://www.ncbi.nlm.nih.gov/pubmed/35677350
http://dx.doi.org/10.2147/JHC.S220978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170176/
https://www.ncbi.nlm.nih.gov/pubmed/35677350
http://dx.doi.org/10.2147/JHC.S220978

Ejemplares similares